COVID-19 in special populations
11. COVID-19 in the immunocompromised host 174
Eric D. Morrell, F. Linzee Mabrey, John S. Goodman, Guang-Shing Cheng and
Kristina Crothers
12. COVID-19 in patients with airways disease: COPD, asthma and 198
bronchiectasis
Lewis Marshall, Emma Johnson and James D. Chalmers
13. COVID-19 in patients with interstitial lung disease 215
Eirini Vasarmidi, Pierre Le Guen, Tiphaine Goletto and Bruno Crestani
Post-COVID syndrome
14. Long COVID: epidemiology and clinical impact 227
Joan B. Soriano, Pilar Rodríguez-Ledo and Julio Ancochea
15. Long COVID: pathological mechanisms 240
Rosemary J. Boyton and Daniel M. Altmann
16. Long COVID: current management and future prospects 250
Felicity Liew and Peter J.M. Openshaw
The legacy of the pandemic
17. COVID-19 platform trials: insight and lessons in clinical trial design 278
Benjamin J.M. New, James D. Chalmers and Jamie Stobo
18. Publishing the pandemic: the impact of COVID-19 on science and 295
scientific publishing
Martin Kolb, Jadwiga A. Wedzicha and James D. Chalmers
19. Future perspectives: preventing the next pandemic 300
Catia Cilloniz, Juan M. Pericas and Rok Čivljak
Previous Page Next Page